Nanjing Sanhome Pharmaceutical Co., Ltd. Business Development & Recruiting Event in San Francisco

The chairman & CEO of Nanjing Sanhome Board, Dr. Yong Wang, with a group of 20 delegates from the Sanhome Board and Senior Management, will join a business development & recruiting event at 1:00 pm on Aug 20^th at LKSC 120 Stanford University. 

Dr. Wang will introduce Sanhome Pharmaceutical and share his 20-year experience in establishing a pharma company in China and how to bring Class I innovation drug to China market.  Sanhome is:

• l  Recruiting a CSO, who will be in charge of global R&D pipeline and overall operation, location: Nanjing
• l  Recruiting principle and senior scientists in different departments, over 30 positions, location: Nanjing
• l  Looking for merger and acquisition opportunities of therapeutic companies including preclinical and clinical trial projects and products
• l  Looking for investment opportunity in biotech companies, including small molecule and large molecule therapeutics
• l  Looking for other business partnering opportunities in new drug R&D to enrich the pipeline of Sanhome which has applied for IPO

Time & Location

• ·         1:00 pm – 4:00 pm, Sunday, 20^th August, 2016. Contact Phone:  317-504-6592.
• ·         LKSC 120, Stanford University, 291 Campus Drive, Palo Alto, CA94305.

Organisers

• ·         Nanjing Sanhome Pharmaceutical Co., Ltd. & Chinese American Bio/pharmaceutical Society.
• ·         Thanks for the support from Association of Chinese Students and Scholars at Stanford.

Schedule

• ·         1:00 – 1:30, Sign in and network
• ·         1:30 – 1:40, Introduction of CABS
• ·         1:40 – 2:40, Introduction of Sanhome, by the president, Dr. Yong WANG
• ·         2:40 – 3:00, Q & A
• ·         3:00 – 4:00, Refreshment & reception

Introduction

• ·         Founded in 1996;
• ·         At the end of this year, total employees expect to reach 2,500, 10-15% are R&D staffs including 200 with Ph.D. or Master degrees;
• ·         R&D centre with over 8.6 acres, a pharmaceutical plant, a bulk pharmaceutical chemicals plant, a GAP level cultivation base, and with more than 400 branches or offices all over China;
• ·         GMP certificated, ‘State high-tech innovation enterprise’ by China MST,  A top 100 pharmaceutical enterprise in China;
• ·         Have developed 1^st class new drugs and exclusive products, and holds 8 overseas patents, 34 China patents and more than 100 new drugs certificates;
• ·         Undertakes ‘863’ and other national major projects, with a post-doctoral working station;
• ·         R&D budget 200 million CNY this year, which represents 9% of the total sales; will increase to no less than 15% and the total R&D budget will be over 1 billion CNY within 5 years.

Requirements

• ·         Chief Science Officer（CSO）：Ph.D. with 5-10 years of experiences in pharmaceutical industries;

Salary & welfare

• ·         Benefits: free housing, stock, funding etc.